The Biotech Onion - Seeking Alpha 'The Biotech Onion' Tag RSS Syndication from SeekingAlpha.com SeekingAlpha.com http://seekingalpha.com/author/the-biotech-onion Introgen Therapeutics: Advexin's P-Value Borg - Resistance is Futile http://seekingalpha.com/article/79985-introgen-therapeutics-advexin-s-p-value-borg-resistance-is-futile?source=feed 79985 On May 29, 2008, Joseph Pantginis, a research analyst from Canaccord Adams who covers Introgen (INGN) with a Buy rating, was interviewed by BioWorld Today about Introgen's recently released pivotal data for Advexin (available here under the search term "Introgen").

Even though the pivotal trial's statistical analyses and data had been massaged for what appears to be several years, Introgen was unable to make lemonade out of its Advexin lemon.

]]> Wed, 04 Jun 2008 01:18:56 -0400 The Biotech Onion The Biotech Onion submits:

On May 29, 2008, Joseph Pantginis, a research analyst from Canaccord Adams who covers Introgen (INGN) with a Buy rating, was interviewed by BioWorld Today about Introgen's recently released pivotal data for Advexin (available here under the search term "Introgen").

Even though the pivotal trial's statistical analyses and data had been massaged for what appears to be several years, Introgen was unable to make lemonade out of its Advexin lemon.


Complete Story »]]> INGN The Biotech Onion